SCHEMBL1122672

SCHEMBL1122672

O=C(O)c1ccc(OCCN(Cc2ccccc2)Cc2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.63
NR4A1 P22736 1/20 0.59
NR4A2 P43354 1/20 0.59
NR4A3 Q92570 1/20 0.59
SRD5A2 P31213 1/20 0.55
PLA2G4B P0C869 2/20 0.53
BCHE P06276 4/20 0.53
ACHE P22303 4/20 0.53
MAOB P27338 1/20 0.52
CYP2D6 P10635 2/20 0.50
HTT P42858 2/20 0.50
KCNH2 Q12809 2/20 0.50
EBP Q15125 2/20 0.50
SIGMAR1 Q99720 2/20 0.50
ESR1 P03372 2/20 0.50
CHRM2 P08172 2/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
CHRM1 P11229 2/20 0.50
PTGS1 P23219 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123361 0.86 MAPT (0.67) BCHEACHEMAOBKDM4EMAPT
SCHEMBL14569771 0.85 TSHR (0.69) PKMNR4A1NR4A2NR4A3BCHE
SCHEMBL1122947 0.84 LPAR1 (0.59) PKMNR4A1NR4A2NR4A3PLA2G4B
SCHEMBL5720732 0.84 NR4A2 (0.62) NR4A2SRD5A2MAOBESR1KMT2A
SCHEMBL9112270 0.84 LTA4H (0.57) BCHEMAOBCYP2D6HTTKMT2A
SCHEMBL14569696 0.83 TSHR (0.66) PKMBCHEACHEKMT2ALTA4H
SCHEMBL14558314 0.82 PKM (0.55) PKMNR4A1NR4A2NR4A3SRD5A2
SCHEMBL20249532 0.81 TSHR (0.63) BCHEACHEKMT2ALTA4HMEN1
SCHEMBL11876136 0.81 MAOB (0.46) BCHEACHEMAOBCYP2D6HTT
SCHEMBL11840883 0.81 L3MBTL1 (0.57) BCHEMAOBCYP2D6HTTKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed
EP-1644321-A2 NEW BENZAMIDES AS PPATY MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-04-12 EP disclosed
WO-2004110983-A2 NEW BENZAMIDES AS PPARϒ MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG PKM 1028/4885NR4A1 46/4885NR4A2 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.